Categories: News

NYSE Content Advisory: Pre-Market Update + e.l.f. Beauty celebrates $1 billion acquisition of Hailey Bieber’s rhode brand

NEW YORK, Sept. 5, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Ashley Mastronardi delivers the pre-market update on September 5th

- Advertisement -
  • Stocks are mixed Friday morning following a record close from the S&P 500 on Thursday. Investors are digesting the results from the August jobs report with estimates that the U.S. economy added 75,000 jobs during the month.
  • This data comes less than two weeks before the Fed makes its next decision on interest rates. Investors are heavily pricing in a 25-basis point cut to come out of the central bank’s meeting.
  • NYSE-listed e.l.f. Beauty will ring the Opening Bell to celebrate its $1 billion acquisition of Hailey Bieber’s cosmetics brand, rhode.

Opening Bell
e.l.f. Beauty (NYSE: ELF) welcomes rhode to their family of six brands that fuel the rocket ship of bold disruptors with kind hearts.

- Advertisement -

Closing Bell
The Free Markets ETF (NYSE Arca: FMKT) celebrates the launch of the Free Markets ETF

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2765743/NYSE_Sept_5_Market_Update.mp4 
Logo – https://mma.prnewswire.com/media/2581322/5494091/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–elf-beauty-celebrates-1-billion-acquisition-of-hailey-biebers-rhode-brand-302547694.html

- Advertisement -

Recent Posts

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast,…

10 hours ago

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

14 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

14 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

14 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

14 hours ago